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Abstract. Many different proteins self-aggregate
into insoluble fibrils growing apically by reversible ad-
dition of elementary building blocks. But beyond this
common principle, the modalities of fibril formation are
very disparate, with various intermediate forms which
can be reshuffled by minor modifications of physico-
chemical conditions or amino-acid sequences. To bypass
this complexity, the multifaceted phenomenon of fibril
formation is reduced here to its most elementary prin-
ciples defined for a linear prototype of fibril. Selected
generic features, including nucleation, elongation and
conformational recruitment, are modeled using mini-
malist hypotheses and tools, by separating equilibrium
from kinetic aspects and in vitro from in vivo conditions.
These reductionist approaches allow to bring out known
and new rudiments, including the kinetic and equilibrium
effects of nucleation, the dual influence of elongation on
nucleation, the kinetic limitations on nucleation and fib-
ril numbers and the accumulation of complexes in vivo
by rescue from degradation. Overlooked aspects of these
processes are also pointed: the exponential distribution
of fibril lengths can be recovered using various models
because it is attributable to randomness only. It is also
suggested that the same term ”critical concentration” is
used for different things, involved in either nucleation or
elongation.
Keywords: Self-assembly; fibril formation; amyloid; nu-
cleation; noncovalent polymers.
1 Introduction
Biomolecular complexes are generally made of a given
number of components of various nature, so that their
building is a finite process. By contrast, certain mono-
tone fibrillar complexes are devoid of terminal capping
moieties locking the polymerized components. As a con-
sequence, their size is not precise but remains subject
to depolymerization or growth depending on the con-
centration of their components and on the conditions.
Understanding the fundamental mechanisms underlying
this process, reviewed in [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11],
is important as it can be physiological [12], of practical
interest for food proteins [13] and for biotechnological
purposes in tissue engineering [14], but also often patho-
logical, for example in the cases of prion, amyloid or tau
proteins in degenerative brains and mutant hemoglobin
S in sickle cells. Although the most popular fibrillation
substrates are proteins, fibrils can also be obtained with
other molecules: short peptides such as polyalanines,
polyglutamines, the hexapeptide VQIVYK from the tau
protein [15] or ultrashort peptides [16, 14], and even
non-protein small molecules [17], suggesting the existence
of abiotic and perhaps prebiotic [18] general fibrillation
principles going beyond the sole field of proteins. Fibril
formation can be studied kinetically [19, 20, 21, 22, 23]
and at equilibrium [19, 24, 1]. Kinetic studies examine
the transient behaviors of fibril formation, such as its sig-
moidicity in time or the existence of lag-phases, whereas
equilibrium corresponds to a stable state observed long
after addition of a given amount of fibril components
in a closed container. In vivo conditions do not cor-
respond to equilibrium but are more complex, because
of the presence of many additional molecular machiner-
ies and of the continuous synthesis and removal of fibril
constituents. As fibril formation can be slow in vivo, it
is often reproduced at higher rate in vitro, in optimized
experimental conditions and using large concentrations
of pure protein, either full length or reduced to short
fibrillation-prone domains.
The very rich literature in this field shows that fibril for-
mation is a multifaceted phenomenon subject to inter-
ferences with a lot of parameters which cannot be taken
into account simultaneously. It can proceed with differ-
ent nucleation intermediates and different modes of poly-
merization [19, 23, 25, 26, 27] which depend on minor
experimental changes or substitution of a single amino-
acid, so that exhaustive models of fibril formation seem
definitely unrealistic. In such a complex situation, it is
often fruitful to recourse first to reductionist approaches
for identifying general principles which can be combined
and adapted to the specificities of real types of fibril. For
comparison, ideal gases with monoatomic particles which
obey perfectly elastic collision rules, do not exist in na-
ture but have allowed to recover universal laws of statis-
tical thermodynamics. This task would have been much
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more difficult by taking directly into account the precise
shapes of the diatomic molecules of nitrogen and oxy-
gen and the complex resulting collisions. In the present
study, instead of starting from non-universal parameters
such as the spatial organization of particular amyloid
crystals, a series of basic features of fibril formation have
been selected for focusing on thermodynamic principles.
Only rudimental fibrils are considered, reduced to linear
protofibrils before their possible subsequent association
in twisted bundles. Their polymerization is analysed un-
der its different facets, either direct or subsequent to a
nucleation process, with or without random fragmenta-
tion, transient or in equilibrium, in vitro and in vivo. The
appropriate tool for the discrete dynamic modelling of
fibril polymerization is the master equation which allows
to enumerate all the binding steps, such as for example
in [10], but shortcuts are proposed here with continuous
ordinary differential equations.
2 Elongation: a question of bind-
ing propensity
Let us call S a fibril-prone substrate. If a large initial con-
centration of monomers [S]0 is let in favorable physico-
chemical conditions (temperature, pH, salts, etc.) for a
very long time in a container of volume V , S will be
found in various forms including S1, the elementary sub-
unit and Sj , the fibrils containing j subunits. Fibril poly-
merization will be assumed noncooperative, which means
that the same binding equilibrium constant K (the ratio
between the association over dissociation rate constants
K = ka/kd), holds for all the steps. This approximation
is acceptable as a change of K in the course of elongation
would not seem in line with the monotonicity of long fib-
rils. In a closed system and in absence of cooperativity,
the tendency to form fibrils is mainly dictated by two
parameters: the affinity of the subunits for the tip of
the fibril (K) and the concentration of free subunits [S1].
The product of these two parameters gives a very useful
dimensionless entity, written below K[S1] = x, which de-
scribes well the elongation propensity. Every polymerisa-
tion step Sj +S1 
 Sj+1 is the resultant of the opposite
reactions of association (rate ka) and dissociation (rate
kd), which balance each other at equilibrium.
ka[S1][Sj ] = kd[Sj+1] (1a)
so that
x = K[S1] =
[Sj+1]
[Sj ]
(1b)
This simple expression suggests that as long as x > 1,
for every step j, [Sj+1] > [Sj ] and fibrils are promoted.
Conversely if the total concentration [S]0 is such that
K[S]0 < 1, no fibrils are expected. They can how-
ever form upon stochastic fluctuations and can even-
tually be stabilized by additional capping components.
When [S1] = 1/K = Kd, for every j, [Sj+1] = [Sj ],
polymerization and depolymerization compensate each
other. Hence, the so-called critical monomer concentra-
tion is close to Kd in supersaturated mixtures. The value
of monomer concentration koff/k+ determined in [10] us-
ing the master equation as the asymptotic limit of a dy-
namic system at infinite time, is completely equivalent to
Kd. When the initial input of monomers is much higher
than Kd ([S]0 >> Kd), calorimetry experiments showed
that fibril elongation is an exothermic driven process [28].
In this treatment, all the polymerization steps, including
the first one, have the same binding constant, but in gen-
eral, fibril formation can be restricted by a safety bolt:
the difficulty to prime the process, called primary nucle-
ation.
3 Primary nucleation
Adding a subunit to a nascent fibril is much more prob-
able than the initial formation of a minimal fibril primer
called nucleus. The nucleus is generally made of several
monomers (Fig.1).
Figure 1. n-order reaction model to explain the restrict-
ing effect of primary nucleation on fibril formation. (A)
Nucleation-independent and (B) nucleation-dependent fibril
formation. Nucleation is necessary when the addition of one
monomer necessitates interaction with several subunits from
the nascent fibril. In the drawing (B), each subunit should
interact with at least two orthogonal subunits to be stabilized.
Real situations are however very complex because
the nucleus components can be themselves pre-assembled
composite building blocks, such as in the case of amyloid
built by stacking layers of beta-sheets resulting from the
assembly of beta-strands [29].
Several mechanisms have been proposed for modeling the
limiting effect of nucleation. Three main characteristics
of nuclei: (i) existence of lag time, (ii) critical concen-
tration and (iii) seeding, have been simulated for amy-
loid fibrils using a lattice Monte Carlo procedure [27].
These properties can be also uncovered using classical
mass action treatments when considering that nucleation
results from either (i) a n-order reaction, whose rarity
results from the necessity of simultaneous collisions be-
tween several monomers [7], (ii) from a difficult dimer-
ization [1, 30, 31], (iii) from a series of binding steps in
which the tendency of dissociation is higher than that of
association, as in the schemes of [32, 33, 34], or (iv) from
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the preliminary conformational activation of monomers,
through spontaneous [35] or induced transconformation
[36, 37] (see section 8.3).
3.1 n-order binding reaction
The addition of a new subunit to a nascent fibril is stabi-
lized by simultaneous interaction with several previously
incorporated subunits (Fig.1B). As this is impossible for
bimolecular reactions in the initial steps, polymerisation
can start only from a nucleus. In the n-order mechanism,
the nucleus does not result from one-by-one addition of
monomers but from a collision between more than two
(say n) subunits. This mechanism gives to the equilib-
rium binding constant a unit of concentration1−n. When
equilibrium is reached, this constant can be expressed
with concentrations as
K∗n =
[Sn]
[S1]n
(2)
where Sn is the primary nucleus [7]. n-order binding
reactions are rare for spatio-temporal reasons. Trimolec-
ular collisions are infrequent and, in addition, the correct
orientation of more than two monomers for interacting
properly is very improbable. This model of nucleation
introduces a sort of cooperativity between the reactants
(a genuine Hill cooperativity) which makes the forma-
tion of fibrils nonlinearly dependent on the dose of fibril
components, as usually approximated [19]. Higher than
bimolecular reactions are so rare that they are generally
neglected in biochemical modeling, but they can play a
role in the particular case of the slow incubation of pro-
tein aggregation diseases, of which they are the limiting
step.
3.2 Backward random walk
The model of nucleation through a series of endother-
mic binding steps of [32, 33, 34], is more realistic than
a global collision and is equivalent to a predominantly
backward random walk whose frequency of completion
is low. The mean time of completion of such walks
dramatically increases with the number of steps, since
it depends on the product of the ratio of the dissocia-
tion over the association rates for all the successive steps.
These theoretical models of nucleation are of course
simplified compared to real systems, such as cross-beta
amyloid structures made of intertwined layers of beta-
sheets. In the n-order reaction and unfavorable random
walk mechanisms, an ambiguity exists about the defini-
tion of the nucleus. In the simplified scheme of Fig.1B,
the unstable version of the nucleus is a trimer, as gen-
erally assumed for actin filaments, whereas the minimal
stable version of the nucleus is a tetramer. Indeed, the
addition of the 4th monomer can also be considered as
the first step of the elongation phase. In the rest of
the present study, the nucleus will be considered as the
greater unstable multimer before stabilization by elonga-
tion, in accordance with the view of [38, 39] considering
the nucleus as the summit of unstability in the whole
process. These unstable nuclei can then be locked by the
ratchet effect of subsequent polymerization.
4 Equilibrium behaviors of fibril
formation
4.1 Detailed balance relations of elonga-
tion
Equilibrium corresponds to in vitro systems in closed
containers disconnected from the environment, but it is
a macroscopic state that is not static at the microscopic
level. Once formed, fibrils seem to be static structures,
but in certain conditions, there are permanent exchanges
between fibrils and free components [40], with a measur-
able ”off rate” [41]. This reversible mode of complex
formation can be briefly described in the case of uniform
fibrils made of the same building block. Monomer addi-
tion will be supposed restricted to the apex of nascent fib-
rils, so that polymerisation is hierarchical, without need
for complex statistical balancing between the microscopic
and macroscopic equilibrium binding constants. The to-
tal amount of substrate [S]0 takes many forms whose
concentrations obey
[S]0 = [S1] + 2[S2] + 3[S3] + .... =
V [S]0∑
j=1
j[Sj ] (3)
These different concentrations are linked together by
the equilibrium constant as follows
[S2] = K[S1]
2 (4a)
[S3] = K[S1][S2] = K
2[S1]
3 (4b)
etc,
[Sj ] = K
j−1[S1]j (4c)
Hence, using x = K[S1], Eq.(3) is close to
K[S]0 =
∞∑
j=1
jxj (5)
When x < 1, this series is convergent and its sum is
K[S]0 =
x
(1− x)2 (6)
The equilibrium concentration of fibrils containing j
subunits is [Sj ] = x
j/K, where x is related to the to-
tal amount of protein through Eq.(6). For simplicity,
fibrils are considered as molecular complexes with more
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than one subunit written [SF ] =
∑V [S]0
j=2 j[Sj ] so that
[S]0 = [S1] + [SF ]. The concentration of fibrils is
[SF ] =
x2(2− x)
K(1− x)2 (7)
But in general, turbidity appears for fibrils larger than
dimers, say r or more subunits. The concentration of
turbid fibrils is
[S]≥r =
x
K
∞∑
j=r
jxj =
x
K
 ∞∑
j=0
jxj −
r−1∑
j=0
jxj

=
rxr − (r − 1)xr+1
K(1− x)2 ∼
rxr
K(1− x)
(8)
The combination of two parameters [S]0 and K dic-
tates the fate of the system. Using Eq.(6), the final
amount of non-monomeric substrate [SF ] = [S]0 − [S1]
can be defined as a function of the total amount of sub-
strate [S]0 and of the binding equilibrium constant K as
follows,
[SF ] = [S]0− 1
K
(
1 +
1
2K[S]0
−
√
1
K[S]0
(
1 +
1
4K[S]0
))
(9)
whose shape is represented in Fig.2.
4.2 Effect of primary nucleation on equi-
librium fibrillation
When the nucleation of a n-mer nucleus is a prerequisite
for fibril elongation, the total amount of fibril compo-
nents spreads over the following species
[S]0 = [S]1+n[Sn]+(n+1)[Sn+1]+....+(n+j)[Sn+j ]+...
(10)
If nucleation proceeds through the n-order mecha-
nism postulated above, Eq.(10) can be rewritten
[S]0 =[S1] +K
∗
n[S1]
n(n+ (n+ 1)x
+ (n+ 2)x2 + ....+ (n+ j)xj + ....)
(11a)
with K∗n defined in Eq.(2). This gives
[S]0 =
x
K
+K∗n
( x
K
)n( n
1− x +
x
(1− x)2
)
(11b)
As previously in absence of nucleation, the total amount
of fibrillar substrates can be defined. It depends now on
three parameters: K,K∗n and [S]0. [SF ] is a solution of
the equation
n− (n− 1)K([S]0 − [SF ])
(1−K([S]0 − [SF ]))2 K
∗
n([S]0 − [SF ])n − [SF ] = 0
(12)
where K and K∗n are fixed constants depending on the
molecular structures, but [S]0 can be modified. Fig.2
shows the concentration-dependence of fibrillation for
given values of K and K∗n. The strong threshold ef-
fect obtained is a clear marker of nucleation. Using this
criterion, the fibrillation of actin [42], tau [31] and β-
lactoglobulin [13], is nucleation-dependent, whereas this
is not the case, or very faintly, for collagen, based on
the results of [43]. Concentration-dependent fibrillation
curves without and with nucleation are clearly different
at low substrate concentration (Fig.2) but converge to-
wards the same asymptote [S]0− 1/K in supersaturated
conditions.
Figure 2. Comparative concentration-dependence of fibril-
lation with and without nucleation. The amount of fibrillar
substrate [SF ] is linearly dependent of the total amount of
susbtrate [S]0, over a threshold concentration. The dotted
curve obtained in absence of nucleation is drawn to Eq.(9)
with K = 0.5 c−1. The plain line is obtained with primary
nucleation by solving Eq.(12) for n = 3 and then using the
values K = 0.5 c−1 and K∗n = 10
−4 c1−n, where c is the
concentration unit.
Hence, this treatment shows that the concept of criti-
cal concentration is ambiguous and used in the literature
for different things. The concentration of substrate corre-
sponding to the sharp bend of the curve with nucleation,
is called critical concentration but has nothing to do with
the critical concentration common to the two curves with
and without nucleation (Fig.2). The first one is a func-
tion of nucleation and elongation parameters, while the
second one is simply Kd.
4.3 Distribution of the subunits between
the fibrils
The concentration of fibrils of size j determined at equi-
librium in [44, 23, 10], is in the style
[Sj ] = K
∗
n[S1]
n(K[S1])
j−n (13)
This distribution can contain a peak when fibril
growth and fragmentation are mixed in a master equa-
4
tion approach in [10]. As [S1] approaches 1/K near equi-
librium in supersaturated conditions, all the fibril sizes
would be equiprobable with Eq.(13), which does not pre-
dict the observed exponential length distribution. Alter-
native equations are proposed below.
In fact, the exponential distribution of fibril lengths, of-
ten verified experimentally, is the result of a series of in-
terfering phenomena, including primary nucleation, com-
plete fibril dissolution, fibril fragmentation and rejoining,
which can not be taken into account simultaneously in
modeling. But it is suggested here that this is not really a
problem because even when considered by subsets, these
mechanisms result in an exponential distribution typical
of random events. Different mechanisms leading to this
distribution will be proposed for fibrils. The first one
is the distribution of subunits on nuclei. When reach-
ing equilibrium with a supersaturated mixture (x ∼ 1),
[S1]eq ∼ Kd and [SF ]eq ∼ [S]0−Kd and fibril polymeriza-
tion becomes a symmetric random walk because the ten-
dencies of association and dissociation equalize. In the
absence of fragmentation and in case of polarized (sin-
gle end) elongation, the concentration of fibrils of any
size corresponds to that of primary nuclei. Supposing
that nuclei are stable and that their size is negligible
compared to that of fibrils, the concentration of fibrils
containing j subunits is
[Sj ] = [SF ]P (X = j) (14)
where P (X = j) is the probability that a given fibril con-
tains j subunits. The mean length of fibrils is dictated by
the concentration of nuclei [N ]. The number of nuclei is
V [N ] and the total number of subunits inserted in fibrils
is V ([S]0− [S1]). When equilibrium is reached, [S1] fluc-
tuates around Kd and the subunits freely and randomly
jump between fibrils. These indiscernible subunits dis-
tribute over the nuclei in a manner similar to the random
distribution of Maxwell-Boltzmann such that
P (X = j) =
e−j/λ∑V [SF ]
k=0 e−k/λ
(15a)
where λ is the mean number of subunits per fibril
λ =
[SF ]
[N ]
∼ [S]0 −Kd
[N ]
(15b)
Hence, for a very large total number of subunits, the
above equations yield
[Sj ] = ([S]0 −Kd)
(
1− e−
[N]
[S]0−Kd
)
e−j
[N]
[S]0−Kd (16)
whose shape is represented in Fig.3.
Figure 3. Relative representation of the different sizes of
fibrils according to Eq.(16). This curve shows that: (i) the
sizes of the fibrils are exponentially distributed for a given
ratio of concentration nuclei/substrates, (ii) fibrils are shorter
when the concentration of nuclei is high compared to that of
substrates, and (iii) fibrils are very long when the concentra-
tion of nuclei is very low (but not zero).
After these equilibrium considerations, let us now
summarize different kinetic properties of fibril formation.
5 The transient primary nucle-
ation
The delay introduced by nucleation, combined to sat-
uration, is a well established recipe for generating the
sigmoidal kinetics of fibril accumulation according to the
simplified system described by Eq.(17). This system as-
sumes the absence of fragmentation, nucleation through
a n-order reaction and irreversible elongation. The rates
of nucleation, de-nucleation and elongation are written
u, d and p respectively. Starting from monomers only,
the concentrations of monomers (S1), of primary nuclei
(PN), of fibrils (F ) and of fibrillar substrate (SF ), evolve
according to
d[S1]
dt
= −nu[S1]n +nd[PN ]− p[S1]([PN ] + [F ]), (17a)
d[PN ]
dt
= u[S1]
n − d[PN ]− p[S1][PN ], (17b)
d[F ]
dt
= p[S1][PN ], (17c)
[SF ] = [S]0 − [S1]− n[PN ]. (17d)
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In this system, the accumulation of primary nuclei is
transient (Fig.4), because fibril elongation progressively
depletes the medium in free monomers thereby forbid-
ding further formation of primary nuclei.
Figure 4. Transient rise of free primary nuclei according to
Eq.(17) with u = 0.1 c1−n t−1, d = 1 t−1, p = 3 c−1 t−1, and
n = 3, where c is a concentration unit and t is a time unit
adapted to the kinetic specificity of the system.
6 Kinetics of elongation
6.1 Stepwise kinetics
Even in the absence of nucleation and saturation, the
mere process of stepwise monomer addition is expected
to give a sigmoidal increase of turbidity, more or less
fugitive depending on the polymerization rate. For ex-
ample, let us suppose that fibril formation is measured
by turbidimetry and that turbidity is generated by fibrils
containing r subunits or more, appearing when [S1] re-
mains much higher than the concentration of nuclei and
the pseudo-first order monomer addition rate β = p[S1]
is roughly constant. The concentration of the substrates
included in turbid fibrils is
[S]≥r ≈ [S]0P (X ≥ r) (18a)
where P (X ≥ r) is the probability that a given fibril in-
cludes r or more subunits, this probability is the comple-
ment to unity of the sum of the probabilities to contain
0, 1, 2, 3,.... until (r − 1) subunits
P (X ≥ r) = 1−
r−1∑
j=0
P (X = j) (18b)
where each P (X = j) is part of a system
dP (X = j)
dt
= β [P (X = j − 1)− P (X = j)] (18c)
which gives the series
[S]≥r(t) ≈ [S]0
1− e−βt r−1∑
j=0
(βt)j
j!
 (18d)
giving a nice sigmoidal arrival time.
6.2 Elongation freezes primary nucle-
ation
The fibril length distribution given by Eq.(16) is valid
but not useful in this form because the concentration of
nuclei is unknown. This number depends on the mecha-
nism of nucleation, primary or secondary. In the absence
of secondary nucleation, the number of primary nuclei is
a ”kinetic legacy” which depends on the delicate balance
between nucleation and polymerization. Indeed, once the
first nuclei appear, they prime polymerization, which in
turn lowers [S1], thereby limiting subsequent nucleation
because it is critically dependent on a threshold of [S1].
Hence, the concentration of primary nuclei does not obey
a simple rule because they can form only at a stage pre-
ceding the elongation phase during which [S1] dramati-
cally drops. The formation of free primary nuclei (PN)
is transient but in case of irreversible fibril formation,
they become embedded in fibrils and prevented to dis-
mantle. The final concentration of nuclei results from
the accumulation of nuclei during the nucleation window
[PN ]final =
∫ ∞
t=0
[PN ](t) dt (19)
where [PN ](t) is a convergent function of time (Fig.4)
governed by the system of Eq.(17). The locking of pri-
mary nuclei is ensured by polymerization which can be
approximated as irreversible during the nucleation phase
during which [S1] is high. If polymerization is exother-
mic reversible and if [PN ]final is small enough compared
to that of the polymerized substrate, the number of fib-
rils is expected to remain stable. In this scenario, a past
transient period of primary nucleation remains inscribed
in the number of fibrils (in the absence of fragmenta-
tion). This puzzling kinetic legacy also holds for other
phenomena such as the long-term maturation [45], slow
gelation [19, 46] and slow compaction of fibrils. In ap-
parently similar conditions, old fibrils no longer dissolve
upon dilution [47]. This age-dependent apparent irre-
versibility can reflect slow inter-subunit induced fit mech-
anisms further stabilizing the fibrils or the formation
of interlocked fibril bundles. These singular situations
highlight the complexity of protein aggregation processes
with their multiple time scale separations, making diffi-
cult to distinguish transient from equilibrium phenom-
ena. A fundamental property of hierarchical exother-
mic polymerization is that the addition of every sub-
unit prevents the depolymerization of previously incorpo-
rated subunits. When exothermic polymerisation follows
endothermic nucleation, the initial polymerization steps
work as a fluctuation ratchet stabilizing the unstable nu-
cleus, as schematized in the simplified energy landscapes
of Fig.5.
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Figure 5. Energy landscapes illustrating the ratchet effect
of polymerization on nucleation, with two models: (A) One-
step, n-order nucleation reaction. (B) Nucleation made of a
series of endothermic reactions.
The concentration of primary nuclei established tran-
siently can be frozen by (i) stabilization through the
ratchet effect of elongation and (ii) by forbidding the
formation of new primary nuclei because of the decrease
of [S1] (illustrated later in the example of Fig.10).
7 Kinetics of fragmentation
The need for nucleation can strongly limit the onset of
fibrils, but once nascent fibrils are present, exothermic
elongation can proceed at a relatively high rate. How-
ever, the overall elongation rate is constrained by the
number of nuclei and fibril ends present in the mix-
ture. In this respect, a particularly important param-
eter favouring fibril formation is the secondary forma-
tion of elongation primers. A predominant and natu-
ral way to achieve this end is the fragmentation of fib-
rils. Incidentally, this phenomenon is expected to be a
major therapeutic problem for the development of fibril-
dissolving drugs aimed at treating aggregation patholo-
gies. The treatment can be worse than doing nothing
when fibril fragmentation multiplies the number of elon-
gation primers and of toxic oligomers. Fragmentation is
expected to decrease in fibril systems at rest at a tem-
perature where only small molecules can diffuse, but a
permanent balance between fragmentation and dissolu-
tion/joining is however very likely in most real systems.
7.1 Elongation-fragmentation amplifica-
tion cycles
Fibril fragmentation can be spontaneous or provoked by
certain proteins such as protein chaperones [48]. Frag-
mentation would strongly increase the overall rate of fib-
ril formation through bypassing the need for rate limit-
ing nucleation of monomers. This multiplication of elon-
gation templates (seeding) exists naturally [49] and can
of course be intensified by experimental fragmentation
[50, 51]. If secondary nucleus doubling occurs over a
critical size of fibrils, its modeling is equivalent to that
of the well-known growth of a bacterial culture. In a
closed container, as for bacterial growth curves, there is
an exponential phase followed by a saturation phase.
7.2 Random fragmentation
The exponential fibril size distribution obtained in full
equilibrium in Section 4.3, holds more generally, even in
steady state for random modes of fragmentation. For ex-
ample, let us postulate the existence, at the microscopic
level, of invisible defective inter-subunit links randomly
incorporated in the course of polymerization. These frag-
ile points would break by Brownian resonance or un-
avoidable mechanical stress. If the mixture contains D
defective links and S non-defective subunits, the proba-
bility that a given fibril contains δ subunits is
P (L = δ) =
(
S
D + S
)δ (
D
D + S
)
(20a)
whose continuous approximation is the probability den-
sity function of Boltzmann, like Eq.(15a). The probabil-
ity that fibrils are longer than δ is simply
P (L > δ) =
(
S
D + S
)δ
(20b)
This equation can be rewritten using the mean number
of subunits per fibril λ = S/D
P (L > δ) =
(
λ
1 + λ
)δ
(20c)
For large λ and δ, the continuous approximation of this
function is
P (L > δ) = e−δ/λ (20d)
Once again the geometric distribution is obtained.
It can be truncated since small fibrils shorter than and
around the nucleus size are absent, thereby generating
a peak in the length distribution. The length distri-
bution curves obtained by random fragmentation (this
section) or random distribution over the primary nuclei
without fragmentation (section 4.3), are closely resem-
bling. Similar shapes of distribution curves have been
obtained experimentally for the time-independent expo-
nential distribution of Hemoglobin S fiber lengths [52]
and for α-synuclein [53].
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7.3 Fragmentation-driven fibril forma-
tion
When S1 is abundant, one can define a pseudo-first order
rate monomer addition to a fibril end β = p[S1] where p
is the intrinsic second order polymerization rate. For
simplicity, the concentration of the monomers will be
considered high enough to neglect the rate of depoly-
merisation. In the random mode of fibril fragmentation
considered above, for a polarized growth and assuming
that the rate of polymerization is constant, the doubling
time (or fibril generation time), is τ = λ/β and as long
as [S1] is not limiting, the proliferation of fibrils follows
[SF ](t) = [SF ]0 2
t/τ = [SF ]0 2
βt/λ (21)
7.4 Saturation of fragmentation-
dependent fibril formation
In a closed container not resupplied with monomers, the
doubling time is not constant but evolves at each fibril
generation such that
[SF ](t+ τ(t)) = 2[SF ](t) (22a)
and
τ(t) ≥ λ/(p([S]0 − [SF ](t)) (22b)
Hence, [SF ] increases less and less rapidly because
the doubling time is longer and longer as [S1] decreases.
The saturation thereby generated can be modeled sim-
ply. During the elongation phase driven by fragmenta-
tion, the role of primary nucleation is negligible and the
time evolution of secondary nuclei [N ] can be calculated
as follows. The amount of substrate incorporated into
fibrils satisfies
d[SF ]
dt
= p[N ][S1]− q[N ] (23a)
where p and q are the rates of polymerization and de-
polymerization and with [S1] = [S]0 − [SF ]. If the nuclei
duplicate after adding λ subunits per fibril, the concen-
tration of elongation primers is related to that of poly-
merized substrate through [SF ] = λ[N ]. Hence, if calling
a = (p[S]0 − q)/λ, the previous equation becomes
d[N ]
dt
= [N ](a− p[N ]) (23b)
Starting at t0 = 0 from a concentration of nuclei
[N ]0 < a/p, we find
[N ](t) =
[N ]0eat
1 + pa [N ]0(e
at − 1) (23c)
which gives a S-shaped growth curve starting from [N ]0
(Fig.6).
Figure 6. Nucleus amplification and saturation. Scheme
drawn to Eq.(23c) with [S]0 = 30 c, [N ]0 = 0.1 c, p = 1 c
−1
t−1, q = 0 t−1 and λ = 40.
8 Kinetics of nucleation
Nucleation is a rare event that is locked by the ratchet ef-
fect of subsequent polymerization. This situation can be
modeled in different manners depending on the mecha-
nism of nucleation retained, but with different equations,
the n-order reaction and the random walk models of nu-
cleation yield very similar results, as described below.
8.1 Nucleation based on a n-order reac-
tion
In the scheme
S1
u−⇀↽−
d
Sn
p−⇀↽−
q
Sn+1
u is a n-order rate of one-step aggregation of n sub-
units into an extremely fragile nucleus Sn, prompt to
dismantle with a high rate d, unless it is locked by poly-
merization (rate p) supposed to be much higher than q
during the nucleation-dominated phase when S1 is abun-
dant. Starting from monomers only, the probability of
first arrival to Sn+1, is
Pn+1(t) = 1− e−σt
(
σ
µ
sinhµt+ coshµt
)
(24a)
with
σ = (d+ p[S1] + u[S1]
n) /2 (24b)
and
µ =
√
σ2 − up[S1]n+1 (24c)
The appearance of primary nuclei is very transient and
no longer sustainable when polymerization decreases [S1]
below the concentration threshold of nucleation. In this
mechanism, time and substrate concentration work co-
operatively. The priming of elongation is sharply depen-
dent on the concentration of S1 and very rapid once this
threshold is overstepped (Fig.7).
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Figure 7. Lag effect of n-order nucleation on the kinetics of
fibril formation. Curve drawn to Eq.(24) with arbitrary units
(d = 20 t−1, p = 20 c−1 t−1, u = 0.1 c1−n t−1 and n = 6).
No primary nuclei can form below a certain concentration of
S1, which forbids the appearance of new primary nuclei after
depletion of S1 caused by polymerization.
8.2 Nucleation based on an endothermic
random walk
In this interesting model of nucleation, the components
of the unstable nucleus Sn are not brought together in
a unique collision, but pile up step by step (u in c−1
t−1 units) in a thermodynamically unfavorable manner
[32, 33, 34]. Nascent nuclei almost always dismantle be-
fore reaching the (n−1)th step. Considering that the nu-
clei can be stabilized by rapid elongation, the transition
from n − 1 to n is assumed irreversible, whereas all the
previous transitions are endothermic. When the proba-
bility of backward jumps largely exceeds that of forward
jumps (u[S1] << d), the completion of the whole chain
becomes similar to a single jump of very low probability.
The mean time spent in step j compared to that spent
in step n− 1, is
〈ti〉
〈tn−1〉 =
1−
(
d
u[S1]
)n−i
1− d
u[S1]
(25)
so that the partial nuclei are extremely rare and com-
plete nuclei appear occasionally in a probabilistic man-
ner, in a single reaction covering all the steps. This prob-
ability takes the form
Pn(t) ≈ 1− e−kt (26)
in which the global frequency k should now be de-
fined. At each step j, the probability to move forward
instead of backward is u[S1]/(d+ u[S1]), so that for the
n− 1 steps of a complete walk,
k = u[S1]
(
u[S1]
d+ u[S1]
)n−1
(27a)
With the approximation d+ u[S1] ∼ d, one obtains
k =
(u[S1])
n
dn−1
(27b)
and the time course of nuclei accumulation follows
Pn(t) ≈ 1− e−((u[S1])n/dn−1)t (28)
By itself, nucleation is not sigmoidal in time but the
formation of fibrils becomes explosive only when Pn(t)
is significant enough to prime elongation, thereby giving
a sharp time course with a long lag phase. In the two
models of nucleus formation (n-order single reaction and
n-step random walk), the formation of primary nuclei
is similarly dependent on the concentration of S1. This
is not surprising given that a series of fast bimolecular
reactions resembles a single collective reaction.
8.3 Nucleation following recruitment of
malconformed monomers
In the model of nucleation inspired by prions, to be incor-
porated into fibrils, monomers should be first activated
by transconformation. Prion proteins switch from a nor-
mal form S, mainly alpha-helical, to a beta strand-rich
form S∗, called scrapie in reference to the corresponding
pathology. In turn, newly converted monomers become
monomer converters, thereby amplifying a recruitment
chain. In the sporadic form of this pathology, not ge-
netic (familial) or iatrogenic (contamination), the initial
convertion is supposed to result from a stochastic, ex-
tremely improbable single event of very low mean rate
k1, itself resulting from the conjunction of unknown mi-
croscopic events, making sporadic scrapie a ”bad luck”
disease. Once malconformed molecules S∗ are present,
they can then recruit their normal counterparts by in-
ducing their transconformation, in an amplification chain
long modeled in [38] and schematized in Fig.8.
Figure 8. Conformational contagion. Following a difficult
initial conversion of S into S∗, the converted moieties induce
the conversion of their normal counterparts, in a snowball
amplification chain. Three cases are possible in Scrapie with
respect to the rate k1: (i) k1 is very low is sporadic cases, (ii)
k1 is higher in genetic cases of familial mutations in the prion
gene and (iii) k1 can remain very low in case of contamination
by exogenous S∗.
Fig.8 can be translated into
d[S∗]
dt
= k1[S] + k2[S
∗][S] (29a)
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with, in a closed container,
[S] = [S]0 − [S∗] and [S∗](0) = 0 (29b)
The solution of this system, equivalent to that deter-
mined in [38, 6], is
[S∗](t) =
k1(e(k1+k2[S]0)t − 1)
k2[S]0 + k1e(k1+k2[S]0)t
(29c)
S∗ accumulates in a sigmoidal manner similar to that
of Fig.6, except that it starts from 0. The concentra-
tion of nuclei [N ] can result form primary nucleation
or breakage-mediated secondary nucleation etc. There
is a multiplication of possible models by combining the
different elementary submodels described previously. A
minimalist scheme without fragmentation is represented
in Fig.9.
Figure 9. Simplified model of protein aggregation following
recruitment, completing that of Fig.8. S is the properly con-
formed substrate, S∗ is the malconformed substrate and PN
are the unstable primary nuclei. Contrary to nucleation that
is considered as highly reversible (k4 > k3), elongation is as-
sumed to be hard driven, with a quasi-irreversible transition
k5.
If the nucleus is not reduced to a monomer of S∗,
a second lag phase is generated by primary nucleation
in addition to that caused by the inital conversion of
S into S∗ (Fig.10). A set of equations describing this
situation is presented in Eq.(30) assuming the n-order
nucleation mechanism and no secondary nuclei. The
time-dependent concentrations of the normal and mal-
conformed substrate, primary nuclei and fibrillar sub-
strate, evolve according to
d[S]
dt
= −k1[S]− k2[S][S∗], (30a)
d[S∗]
dt
=k1[S] + k2[S][S
∗]− nk3[S∗]n
+ nk4[PN ]− k5[S∗]([PN ] + [F ]),
(30b)
d[PN ]
dt
= k3[S
∗]n − k4[PN ]− k5[S∗][PN ], (30c)
d[F ]
dt
= k5[S
∗][PN ], (30d)
[SF ] = [S]0 − [S]− [S∗]− n[PN ]. (30e)
Eq.(30) gives the sequential profiles shown in Fig.10,
characterized by two lag phases. The fate of this system
is very sensitive to the relative parameter values. For ex-
ample, the recruiting influence of S∗ can be moderated by
its self-sequestration into fibrils, according to Eq.(30b).
As illustrated in Fig.10B, in case of slow conformational
recruitment, the competition between nucleation and re-
cruitment can limit the total amount of malconformed
substrate, and thereby of fibrils.
Figure 10. Two lag phases in the onset of fibrils result-
ing from substrate transconformation. The first lag phase
t1 corresponds to the priming of transconformation and the
second one t2, is the formation of primary nuclei following
accumulation of transconformed substrate above a concentra-
tion threshold. Curves drawn to Eq.(30) with arbitrary time
units and parameters which are: (A) k1 = 10
−4 t−1, k2 = 1
c−1 t−1, k3 = 0.06 c1−n t−1, k4 = 2 t−1, k5 = 6 c−1 t−1 and
n = 3). In (B) the only parameter changed is k2 = 0.1 c
−1
t−1.
9 Kinetic aspects of fibrils in vivo
Most existing models start from a given amount of fibril
constituents in a container, progressively incorporated
into fibrils. In the previous example of prion conta-
gion, an input of transconformational inducer is added
at a given time point in the container. Living systems
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are however not closed containers but are by essence
open. Fibrils ingredients can be synthesized and de-
graded, which seriously interferes with all the previous
modeling attempts. Additional parameters should be in-
troduced for in vivo modeling. Molecular crowding is
important in vivo, particularly for nucleation, but it can
be reproduced in vitro. In fact, the two most important
parameters strictly specific of in vivo conditions are: (i)
the relative kinetics of synthesis and fibril formation. If
the synthesis of [S1] is low, the exponential phase is very
short or inexistent. (ii) The differential susceptibility to
degradation of soluble and insoluble fibril constituents.
This latter point is crucial in the development of slow
conformational diseases. Indeed, it is classically assumed
that protein aggregation results from a defect of protein
degradation, but the inverse is even more important: an
overlooked property of aggregates is their resistance to
degradation, which can ensure physiological roles for pro-
grammed amyloid formation [12], but becomes harmful
for amyloid diseases.
Figure 11. Resistance to degradation of fibril constituents.
(A) Protection by insolubilization following fibril polymeriza-
tion. s and r are the rates of synthesis and removal of the
soluble protein. p and q are the rates of polymerization and
depolymerization. (B) Protection by transconformation into
a protease-resistant structure. This scheme completes in vivo
that of Fig.8 in vitro.
The concentration of free fibril components is, as for
all other soluble proteins, the steady state resultant of
continuous synthesis and degradation. Fibril-prone pro-
teins are synthesized as soluble and their rate of removal
is generally a linear function of their soluble concen-
tration. But once trapped into fibrils, they escape the
degradation system according to the simplified scheme of
Fig.11A. Starting from a concentration [SF ] of monomers
polymerized into fibrils of mean size λ, the total concen-
tration of substrate ([S]tot = [SF ] + [S1]) can increase
unlimitedly in the cell according to the following system:
d[S]tot
dt
= s− r([S]tot − [SF ]) (31a)
d[SF ]
dt
=
p
λ
[SF ]([S]tot − [SF ]) (31b)
A limited rate of synthesis can restrict or forbid the
existence of exponential phases, and the fibrils accumu-
late in a linear function of time (Fig.12).
Figure 12. Fibrils accumulate in vivo when the resistance
to degradation provided by insolubilisation breaks the steady
state. Schemes drawn to Eq.(31) with s = 2 c t−1, p/λ = 3
c−1 t−1, r = 1 t−1, following addition of an input of fibrils
[SF ](0) = 0.1 c, at time 0.
The resistance to proteolysis has long been identified
as the hallmark of scrapie [54] and the primary cause of
prion accumulation after transconformation. Only the
properly folded substrate can be submitted to normal
synthesis/removal turnovers (Fig.11B). The formal dy-
namic treatment of the scheme of Fig.11B gives results
like those shown in Fig.13. The comparison of panels C
and D, in which S is continuously synthesised, is of par-
ticular interest. When only the soluble form is degrad-
able (Fig.13C), S∗ continuously accumulates. By con-
trast, when both S and S∗ are submitted to the same
degradation rate, one obtains a steady state (Fig.13D),
in which s = r([S] + [S∗]). In this scenario, the fate of
the disease depends on whether the value of [S∗] result-
ing from this system is lower or higher than the nucle-
ation threshold, contrary to the case of Fig.13C where
the threshold is necessarily reached sooner or later. In
vivo modeling can be further complexified as desired, for
example by introducing chaperones in the arena, but the
general principle of an accumulation of S in the system
through an escape from normal turnovers, remains essen-
tial.
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Figure 13. Kinetics of prion transconversion based on the
scheme of Fig.11B, in four cases: (A) No synthesis and no
degradation of a finite initial amount of S. (B) Synthesis, but
not degradation of S. (C) Synthesis and degradation of S.
(D) Synthesis of S and degradation of both S and S∗. The
rate constants used for these graphs are s = 1 c t−1, r = 1
t−1, k1 = 0.01 t−1 and k2 = 3 c−1 t−1.
10 Conclusions
The polymorphic molecular process of fibril formation
can be influenced by a virtually endless list of parame-
ters, which depend on the specific cases and on the cir-
cumstances, such as protein disorganization, conforma-
tional changes, diffusion, viscosity, temperature, chaper-
ones, pH, salts, metals, colloidal effects, secondary post-
nucleation pathways, coexistence of multiples modes of
nucleation, fibril branching and rejoining, and many
other ones [22, 23, 25]. To focus on the primary ther-
modynamic determinants of this complex biochemical
process, a compendium of general rules is presented
here, which highlights some problems in studying fibrils,
such as (i) the difficulty to clearly separate transient
from equilibrium phenomena, or (ii) to identify the pre-
cise causes of observations which can be explained by
different models.
(i) In theory, regardless of how they have been estab-
lished, equilibrium states can be entirely described using
detailed balance rules. But it is very difficult in prac-
tice to determine when equilibrium is reached because of
the coexistence of transient phenomena of very different
time scales and of the long term imprinting of transient
processes such as primary nucleation.
(ii) The sigmoidal kinetics of fibril growth sometimes
considered as the hallmark of nucleation, can be un-
derlied by different mechanisms. A good criterion for
assessing the existence of limiting nucleation is a thresh-
old effect at equilibrium (represented in Fig.2). This
threshold is currently called a critical concentration but
this not the same as the critical concentration of elon-
gation. The distribution of fibril lengths has often been
shown exponential [55, 44, 22, 53, 56]. It is suggested
that this distribution is a robust mark of randomness
which holds for different models. All these resemblances
could lead to misleadingly satisfactory curve fitting.
The main simplifying hypothesis facilitating the ordinary
differential modeling used here, is the quasi-irreversibility
of elongation. This approximation has the disadvantage
of leading to the complete depletion of monomers but is
quite realistic during nucleation and the transition phase
between nucleation and elongation [57]. These simplified
tools allowed pointing original mechanisms involved in
fibril formation: Elongation has ambiguous effects on
nucleation: on the one hand stabilizing nuclei through
a ratchet effect, and on the other hand, restricting the
number of primary nuclei through lowering the concen-
tration of monomers. In vivo, protein insolubilization is
expected to play an essential role in amyloid accumula-
tion through the escape from degradation.
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